Skip to main content

Closed

ANVS: Annovis Bio, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Operating margin0.0%

ROIC-1199.7%

Financially safe

Stretched

Debt / equity0.00×

Interest coverage0.0×

Current ratio1.27×

Annovis Bio, Inc.

ANVSNew York Stock Exchange·USD·Closed

Annovis Bio, Inc.

ANVSNew York Stock Exchange·USD·Closed

$1.75

−1.13%

$1.75

−$0.02 (1.13%)

52W Range

5thpctl

Volume

0.32×avg

Mkt Cap

34.43MUSD

P/E

-1.0TTM

Div Yield

–ann

52W Range

5thpctl

Volume

0.32×avg

Market Cap

34.43MUSD

P/E Ratio

-1.0TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings